213 related articles for article (PubMed ID: 17979648)
21. Preparation and evaluation of optimized zolmitriptan niosomal emulgel.
Mohamed MI; Abdelbary AA; Kandil SM; Mahmoud TM
Drug Dev Ind Pharm; 2019 Jul; 45(7):1157-1167. PubMed ID: 30919700
[No Abstract] [Full Text] [Related]
22. Enhanced anti-inflammatory effects of celecoxib from a transdermally applied nanoemulsion.
Shakeel F; Baboota S; Ahuja A; Ali J; Shafiq S
Pharmazie; 2009 Apr; 64(4):258-9. PubMed ID: 19435145
[TBL] [Abstract][Full Text] [Related]
23. Niosome-based hydrogel of resveratrol for topical applications: An effective therapy for pain related disorder(s).
Negi P; Aggarwal M; Sharma G; Rathore C; Sharma G; Singh B; Katare OP
Biomed Pharmacother; 2017 Apr; 88():480-487. PubMed ID: 28126673
[TBL] [Abstract][Full Text] [Related]
24. Preparation, in vitro and in vivo evaluation of liposomal/niosomal gel delivery systems for clotrimazole.
Ning M; Guo Y; Pan H; Chen X; Gu Z
Drug Dev Ind Pharm; 2005 May; 31(4-5):375-83. PubMed ID: 16093203
[TBL] [Abstract][Full Text] [Related]
25. Formulation Optimization and Ex Vivo and In Vivo Evaluation of Celecoxib Microemulsion-Based Gel for Transdermal Delivery.
Cao M; Ren L; Chen G
AAPS PharmSciTech; 2017 Aug; 18(6):1960-1971. PubMed ID: 27914040
[TBL] [Abstract][Full Text] [Related]
26. Effect of non-phospholipid-based cationic and phospholipid-based anionic nanosized emulsions on skin retention and anti-inflammatory activity of celecoxib.
Tamilvanan S; Baskar R
Pharm Dev Technol; 2013; 18(4):761-71. PubMed ID: 23668371
[TBL] [Abstract][Full Text] [Related]
27. Nanostructured Non-Ionic Surfactant Carrier-Based Gel for Topical Delivery of Desoximetasone.
Shah P; Goodyear B; Dholaria N; Puri V; Michniak-Kohn B
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33546426
[TBL] [Abstract][Full Text] [Related]
28. Enhanced transdermal delivery of ketoprofen from bioadhesive gels.
Singh S; Gajra B; Rawat M; Muthu MS
Pak J Pharm Sci; 2009 Apr; 22(2):193-8. PubMed ID: 19339232
[TBL] [Abstract][Full Text] [Related]
29. Enhanced transdermal delivery of luteolin via non-ionic surfactant-based vesicle: quality evaluation and anti-arthritic assessment.
Abidin L; Mujeeb M; Imam SS; Aqil M; Khurana D
Drug Deliv; 2016; 23(3):1079-84. PubMed ID: 25116512
[TBL] [Abstract][Full Text] [Related]
30. Topical delivery of celecoxib using microemulsion.
Subramanian N; Ghosal SK; Moulik SP
Acta Pol Pharm; 2004; 61(5):335-41. PubMed ID: 15747689
[TBL] [Abstract][Full Text] [Related]
31. Sorbitan ester niosomes for topical delivery of rofecoxib.
Das MK; Palei NN
Indian J Exp Biol; 2011 Jun; 49(6):438-45. PubMed ID: 21702223
[TBL] [Abstract][Full Text] [Related]
32. The anti-inflammatory effects of the phosphodiesterase inhibitor pentoxifylline in the rat.
Abdel-Salam OM; Baiuomy AR; El-Shenawy SM; Arbid MS
Pharmacol Res; 2003 Apr; 47(4):331-40. PubMed ID: 12644391
[TBL] [Abstract][Full Text] [Related]
33. Mechanical properties, skin permeation and in vivo evaluations of dexibuprofen-loaded emulsion gel for topical delivery.
Jin SG; Yousaf AM; Son MW; Jang SW; Kim DW; Kim JO; Yong CS; Kim JH; Choi HG
Arch Pharm Res; 2015 Feb; 38(2):216-22. PubMed ID: 24988989
[TBL] [Abstract][Full Text] [Related]
34. Formulation and ex vivo evaluation of rofecoxib gel for topical application.
Das MK; Ahmed AB
Acta Pol Pharm; 2007; 64(5):461-7. PubMed ID: 18540168
[TBL] [Abstract][Full Text] [Related]
35. Enhanced transdermal delivery of lornoxicam by nanostructured lipid carrier gels modified with polyarginine peptide for treatment of carrageenan-induced rat paw edema.
Gao S; Tian B; Han J; Zhang J; Shi Y; Lv Q; Li K
Int J Nanomedicine; 2019; 14():6135-6150. PubMed ID: 31447556
[No Abstract] [Full Text] [Related]
36. Sustained Anti-inflammatory Effect of Resveratrol-Phospholipid Complex Embedded Polymeric Patch.
Kalita B; Das MK; Sarma M; Deka A
AAPS PharmSciTech; 2017 Apr; 18(3):629-645. PubMed ID: 27173988
[TBL] [Abstract][Full Text] [Related]
37. Microemulsion and poloxamer microemulsion-based gel for sustained transdermal delivery of diclofenac epolamine using in-skin drug depot: in vitro/in vivo evaluation.
Fouad SA; Basalious EB; El-Nabarawi MA; Tayel SA
Int J Pharm; 2013 Sep; 453(2):569-78. PubMed ID: 23792042
[TBL] [Abstract][Full Text] [Related]
38. Development of ibuprofen nanoliposome for transdermal delivery: Physical characterization, in vitro/in vivo studies, and anti-inflammatory activity.
Gaur PK; Bajpai M; Mishra S; Verma A
Artif Cells Nanomed Biotechnol; 2016; 44(1):370-5. PubMed ID: 25211229
[TBL] [Abstract][Full Text] [Related]
39. Liquid Crystalline Systems Based on Glyceryl Monooleate and Penetration Enhancers for Skin Delivery of Celecoxib: Characterization, In Vitro Drug Release, and In Vivo Studies.
Dante MCL; Borgheti-Cardoso LN; Fantini MCA; Praça FSG; Medina WSG; Pierre MBR; Lara MG
J Pharm Sci; 2018 Mar; 107(3):870-878. PubMed ID: 29108729
[TBL] [Abstract][Full Text] [Related]
40. Novel Enhanced Therapeutic Efficacy of Dapoxetine HCl by Nano-Vesicle Transdermal Gel for Treatment of Carrageenan-Induced Rat Paw Edema.
Salem HF; Nafady MM; Kharshoum RM; Abd El-Ghafar OA; Farouk HO
AAPS PharmSciTech; 2020 Apr; 21(3):113. PubMed ID: 32291553
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
